Similar efficacy and gastrointestinal tolerability versus exposure for oral and subcutaneous semaglutide
Compounding itself is not new or inherently unsafe
And emerging research suggests direct effects on adipose tissue metabolism that may shift the body toward preferentially burning fat stores rather than lean muscle
Oral administration of myricetin significantly reduces Fe 2+ levels in the substantia nigra of PD rats, inhibits neuronal ferroptosis, decreases ROS production, downregulates malondialdehyde (MDA) and -synuclein (-Syn) expression, elevates GSH levels, and ameliorates motor deficits
Its broad range of effects suggests potential applications for tissue regeneration, gut health, neurological conditions, cardiovascular protection, and chronic pain management